Lon Sbtx News Today

SkinBioTherapeutics plc (LON:SBTX – Get Free Report) shares hit a new 52-week low during mid-day trading on Friday . The company traded as low as GBX 10.76 ($0.14) and last traded at GBX 11.20 ($0.14), with a volume of 3135234 shares trading hands. The stock had previously closed at GBX 12.75 ($0.16). SkinBioTherapeutics Price Performance […]

SkinBioTherapeutics Plc (LON:SBTX – Get Free Report) shares were down 2.4% during mid-day trading on Monday . The company traded as low as GBX 19.04 ($0.24) and last traded at GBX 20 ($0.25). Approximately 442,793 shares were traded during mid-day trading, an increase of 6% from the average daily volume of 418,282 shares. The stock […]

SkinBioTherapeutics Plc (LON:SBTX – Get Free Report)’s share price dropped 3.4% on Monday . The stock traded as low as GBX 21.04 ($0.26) and last traded at GBX 21.50 ($0.26). Approximately 260,935 shares were traded during trading, a decline of 36% from the average daily volume of 409,569 shares. The stock had previously closed at […]

SkinBioTherapeutics Plc (LON:SBTX – Get Free Report) shares reached a new 52-week low during trading on Friday . The stock traded as low as GBX 11 ($0.14) and last traded at GBX 11.80 ($0.15), with a volume of 142093 shares traded. The stock had previously closed at GBX 12.13 ($0.16). SkinBioTherapeutics Stock Performance The stock […]

26 May 2021 | 09:14am StockMarketWire.com - Skin health focused SkinBioTherapeutics said a study of consumers using one of its food supplements had garnered highly positive feedback. The AxisBiotix-Ps powered supplement was designed to modulate the immune system by harnessing the gut-skin axis, to address problems associated with sensitive skin conditions such as psoriasis. A 56-day self-managed consumer study commenced in February with 76% of participants that self-identified as suffering from...

The breakthrough was developed by the companys subsidiary in collaboration with partner Winclove Probiotic SkinBioTherapeutics PLC (LON:SBTX) said a study of people suffering from psoriasis that received its immune system-modulating food supplement delivered results that exceeded expectations. The findings from the assessment of AxisBiotix-Ps, developed in collaboration with partner Winclove Probiotics, will pave the way for a commercial launch of the product in the fourth quarter. In all 91 pe...

SkinBioTherapeutics PLC (LON:SBTX) Stuart Ashman joins Proactive London to discuss results from a study of people suffering from psoriasis that...